Regulatory Updates

Distribution date: 08 January 2021

Notice - The Environmental Protection Agency (EPA) is announcing the availability of the final Toxic Substances Control Act (TSCA) risk evaluation of Asbestos Part 1 (Chrysotile Asbestos). The purpose of conducting risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation, without consideration of costs or other nonrisk factors. EPA has determined that specific conditions of use of Chrysotile Asbestos present an unreasonable risk of injury to health. For those conditions of use for which EPA has found an unreasonable risk, EPA must take regulatory action to address that unreasonable risk through risk management measures enumerated in TSCA. EPA has also determined that specific conditions of use do not present unreasonable risk of injury to health or the environment. For those conditions of use for which EPA has found no unreasonable risk to health or the environment, the Agency's determination is a final Agency action and is issued via order in the risk evaluation. EPA is currently developing Part 2 of the TSCA risk evaluation for Asbestos which will evaluate risk of injury to health or the environment for legacy uses and associated disposals of asbestos. The Agency plans to release a draft scope for Part 2 of the risk evaluation for Asbestos for public comment mid-year 2021.

Products Covered: Asbestos (Chrysotile Asbestos), risk evaluation

Regulation Type: Regular notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1833:2019, Baby oils — Specification; notified in G/TBT/N/UGA/755, G/TBT/N/UGA/755/Add.1 and G/TBT/N/UGA/755/Add.2 was withdrawn on 15 December 2020.

Products Covered: Baby oils.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1833:2019, Baby oils — Specification; notified in G/TBT/N/UGA/755, G/TBT/N/UGA/755/Add.1 and G/TBT/N/UGA/755/Add.2 was withdrawn on 15 December 2020.

Products Covered: Baby oils.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1933:2019, Lip shine (gloss) — Specification; notified in G/TBT/N/UGA/801, G/TBT/N/UGA/801/Add.1 and G/TBT/N/UGA/801/Add.2 was withdrawn on 15 December 2020.

Products Covered: Lip shine, Lip gloss.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1933:2019, Lip shine (gloss) — Specification; notified in G/TBT/N/UGA/801, G/TBT/N/UGA/801/Add.1 and G/TBT/N/UGA/801/Add.2 was withdrawn on 15 December 2020.

Products Covered: Lip shine, Lip gloss.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1934:2019, Aftershave — Specification; notified in G/TBT/N/UGA/802, G/TBT/N/UGA/802/Add.1 and G/TBT/N/UGA/802/Add.2 was withdrawn on 15 December 2020.

Products Covered: Aftershave.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1934:2019, Aftershave — Specification; notified in G/TBT/N/UGA/802, G/TBT/N/UGA/802/Add.1 and G/TBT/N/UGA/802/Add.2 was withdrawn on 15 December 2020.

Products Covered: Aftershave.

Regulation Type: Addendum to Regular Notification

Distribution date: 06 January 2021 | Final date for Comment: 07 March 2021

The amendment to the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was established in December 2019. The amendment to the Act introduced the system in Japan according to which Marketing Authorization Holders (MAHs) basically use electronic methods such as barcodes when providing information on pharmaceuticals and medical devices. The Ordinance for Enforcement of the Act will be amended to specify the details of the system.

Products Covered: (HS code(s): 30, 90); (ICS code(s): 11.040, 11.120)

Regulation Type: Regular notification

Distribution date: 06 January 2021 | Final date for Comment: 07 March 2021

The amendment to the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was established in December 2019. The amendment to the Act introduced the system in Japan according to which Marketing Authorization Holders (MAHs) basically use electronic methods such as barcodes when providing information on pharmaceuticals and medical devices. The Ordinance for Enforcement of the Act will be amended to specify the details of the system.

Products Covered: (HS code(s): 30, 90); (ICS code(s): 11.040, 11.120)

Regulation Type: Regular notification

Distribution date: 06 January 2021

The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1877:2019, Deodorants and antiperspirants — Specification; notified in G/TBT/N/UGA/779, G/TBT/N/UGA/779/Add.1 and G/TBT/N/UGA/779/Add.2 was withdrawn on 15 December 2020.

Products Covered: Shaving preparations, incl. pre-shave and after-shave products, personal deodorants, bath and shower preparations, depilatories and other perfumery, toilet or cosmetic preparations, n.e.s.; prepared room deodorizers, whether or not perfumed or having disinfectant properties (HS code(s): 3307); Personal deodorants and antiperspirants (HS code(s): 330720); Cosmetics. Toiletries (ICS code(s): 71.100.70)

Regulation Type: Addendum to Regular Notification